Deep Genomics

Deep Genomics

  • Founded: 2014
  • Location: Toronto, ON
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: CNS conditions
  • Drug types: NEU, GEN
  • Lead product: Undisclosed
  • Product link:
  • Funding: $40M B Jan 2020
  • Investors: Future Ventures, Amplitude Ventures, Magnetic Ventures, Khosla Ventures, True Ventures

job board

Short description:

AI-discovery, Oligonucleotide Therapies

Drug notes:

Additional undisclosed programs RD CNS conditions, metabolic conditions, undisclosed

Long description:

Deep Genomics is using AI to build life-saving genetic therapeutics. Biology is too complex for the human mind to comprehend, so future drug development will depend on AI assistance. By using the revolutions in AI, RNA biology and automation, Deep Genomics is designing RNA therapies for any gene and any genetic condition. Deep Genomics’ proprietary AI Workbench identifies novel targets from evaluating thousands of possibilities to identify the best therapeutic candidates. Lead candidates have been identified for over 50% of the novel targets Deep Genomics has tested so far. Now, Deep Genomics is creating AI Workbench 3.0 to expand the number of mechanisms and genetic variants analyzed, so the company can tackle complex genetic diseases.


Deep Genomics
Laboratory Operations Associate
Toronto, ONOn-site|4 days ago
Deep Genomics
Senior MLOps Engineer
Toronto, ONHybrid|25 days ago
Deep Genomics
(Senior) Research Scientist - Statistical Genetics...
Toronto, ON|100+ days ago
Deep Genomics
Senior/Lead Scientist - Computational Chemistry
Toronto, ON|100+ days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy